PET developer Positron of Houston has completed the due diligencephase of its planned acquisition of GE Medical Systems' PET business(SCAN 7/31/96). Positron said it is in the latter stages of securingfinancing for the deal, which it expects to have in
PET developer Positron of Houston has completed the due diligencephase of its planned acquisition of GE Medical Systems' PET business(SCAN 7/31/96). Positron said it is in the latter stages of securingfinancing for the deal, which it expects to have in place in fourto six weeks. The company said it hopes to close the deal by theend of this year, after shareholder approval is received.
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.